The mission of the Chicago Biomedical Consortium (CBC) is to stimulate collaboration among scientists at Northwestern University, The University of Chicago, the University of Illinois Chicago and other Chicagoland institutions to accelerate discovery and expand the Chicago based life sciences ecosystem in order to transform life science research into biomedical applications, create inclusive Chicagoland opportunities, and improve the health of humankind.

The CBC gratefully acknowledges support from the Searle Funds at The Chicago Community Trust.

▸ RFA: Accelerator Award

Updated: January 4, 2023
The Accelerator Award is a milestone-driven award program (up to $250,000) focused on translational research toward therapeutics or associated biomarkers and diagnostics.

The Accelerator Award Letter of Intent (LOI) submission portal is now OPEN;
LOI submissions will be accepted on a rolling basis.

Read more

▸ RFA: Entrepreneurial Fellows Award

Updated: May 13, 2023
The CBC Entrepreneurial Fellows (EF) Award program identifies and supports the professional development of junior life sciences researchers who are keen to develop the skills and experiences needed to move translational projects from a university lab toward commercialization and potentially into a Chicago-based biotech start-up. The program exposes Fellows to a breadth of real-world experiences across the CBC institutions and connects trainees to the Chicago biomedical community.

The CBC Entrepreneurial Fellows (EF) Award application submission portal is now CLOSED. Application submission deadline was: May 12, 2023.
Visit us regularly to see when the next round of application submissions will start!

Meet the CBC Entrepreneurial Fellows HERE!

Read more

▸ RFA: Neuroscience Affinity Group Award

Updated: May 31, 2023
The CBC Neuroscience Affinity Group is an inclusive community of Chicago neuroscientists with an overarching goal to provide a framework for selecting high-risk/high-reward research projects in the Neuroscience space. The CBC Neuroscience Affinity Group award can range up to $250,000 total for use over one to two years.

The Letter of Intent (LOI) submission portal for the CBC Neuroscience Affinity Group is now CLOSED. LOI submission deadline was: May 30, 2023.

Check back soon for more information about the fall Affinity Group schedule.

Read more

More programs

▸ CBC Informational Sessions

Updated: May 13, 2023

Biotech Fizzle Thursdays

Join the current CBC Entrepreneurial Fellows at the upcoming CBC Biotech Fizzle Thursdays to learn about the CBC Entrepreneurial Fellows (EF) program and our upcoming application process and deadlines!

Next Available Dates:

  • TBA

Read more

More events

Recent Twitter Posts


Recent CBC News

News  I  June 6, 2023

▸ Chicago Innovators: A four-person cohort may seed the biotech industry in Chicago

CBC Executive Director Michelle B. Hoffmann speaks with Sasha-Ann Simons on WBEZ’s Reset on how the CBC Entrepreneurial Fellows will help ignite our explosive life sciences ecosystem.

Click on the red “listen” button at the beginning of the article to hear the full podcast!

News I June 1, 2023

▸ The Chicago Biomedical Consortium Names Next Class of CBC Entrepreneurial Fellows

CBC Entrepreneurial Fellows program aims to inspire and coach promising local biomedical talent and support the growing life science industry in Chicagoland.

Please see HERE for the Crain’s Chicago Business coverage!

▸ More news


Community, Biotech, & Entrepreneurship

Posted: September 12, 2022
September 22, 2022
Hybrid Event @ Innovation Research Park – Monica Ply Conference, RM 120
Rosalind Franklin University of Medicine and Science
▸ Biomedical Innovation Day
Featuring Keynote Speakers: Niels Emmerich, Abbvie and Paul Weiss, Venture Investors
Join us for a day of conversation around industry partnerships, biomedical discovery and healthcare.

More community, biotech & entrepreneurship


Posted: August 3, 2022
Multiple Job Opportunities:
CTRL Therapeutics
CTRL Therapeutics is an emerging cell therapy company led by a team of serial entrepreneurs and biotech industry veterans focused on unlocking the full potential of autologous cell therapy to transform the treatment of solid tumors. 5 positions in Operations, Research and Process Development are available immediately. The US-based CTRL team will be housed at Portal Innovations at 400 N. Aberdeen St. in Chicago.

▸ Operations Manager
▸ Director/ Associate Director, Process Development
▸ Scientist / Senior Scientist, Process Development
▸ Research Associate, Process Development
▸ Research Scientist/Sr. Research Scientist

More opportunities